AZN vs ISBA · P/E 28, $288.38B cap vs P/E 15, rev $51.3M
AstraZeneca PLC (AZN) versus Isabella Bank Corporation (ISBA) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Isabella Bank Corporation (ISBA) is a banks - regional company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported ISBA revenue for 2026-06-30 was $51.3M. Net income was $10.0M. ISBA currently screens at market cap $211.1M and trailing P/E 14.5.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. ISBA currently screens at market cap $211.1M and trailing P/E 14.5.
Not investment advice. Open the AZN and ISBA stock pages for the full models.
Not investment advice.